Deferasirox Tablet, For Suspension
Product Images NDC 62332-326

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Deferasirox (NDC 62332-326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Deferasirox Figure 1

A bar chart showing the change in liver iron content (mg Fe/g dry weight) and serum ferritin (mcg/L) versus Deferasirox dose (mg/kg/day). Data bars compare liver iron content and serum ferritin changes at doses of 5, 10, 20, and 30 mg/kg/day, with sample sizes indicated for each group.*

FDA Label Image

Deferasirox mg 125

Deferasirox Tablets for Oral Suspension 125 mg per tablet label showing dosing instructions, storage conditions, and manufacturer Alembic Pharmaceuticals Inc. The label includes NDC number 62332-324-30, barcode, and packaging details for 30 tablets with caution to not chew or swallow whole. The label also mentions the tablets must be dispersed in water before use.*

FDA Label Image

Deferasirox mg 250

Deferasirox Tablets for Oral Suspension 250 mg per tablet packaging label by Alembic Pharmaceuticals Inc. It includes dosage information, storage conditions, a barcode, and instructions indicating tablets must be dispersed in water, orange or apple juice before ingestion. The label also specifies the product is prescription only and contains 30 tablets per package.*

FDA Label Image

Deferasirox mg 500

Label for Deferasirox Tablets for Suspension, 500 mg per tablet, manufactured by Alembic Pharmaceuticals Inc. The label includes NDC 62332-326-30, dispensing instructions emphasizing tablets must be dispersed in water or orange/apple juice before ingestion, and a warning not to chew or swallow whole. The package contains 30 tablets and specifies storage at 25°C with excursions allowed. Additional coding area and barcodes are also present.*

FDA Label Image

Structure (Deferasirox Structure)

Chemical structure of deferasirox, showing a triazole ring connected to three phenol groups, representing its molecular composition as a pharmaceutical active ingredient.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.